September 22, 2020

Glucocorticoid Therapy Does Not Delay Viral Clearance in COVID-19 Patients

Category: Article Summary

Topic: Testing and Treatment

Keywords (Tags): treatment

• Glucocorticoid therapy did not change viral clearance or peripheral lymphocyte counts in patients with SARS-CoV-2 infection in a cohort study from two hospitals in China. Time to viral clearance among participants with severe or critical COVID-19 was 26 days in participants who received glucocorticoids (n=72) versus 25.5 days in participants who did not (n=108). In participants with mild COVID-19, it was 23.5 days among participants who received glucocorticoids (n=30) versus 22 days in participants who did not (n=460).

Ji et al. (Dec 21, 2020). Glucocorticoid Therapy Does Not Delay Viral Clearance in COVID-19 Patients. Critical Care. https://doi.org/10.1186/s13054-020-03287-6